8-Sep-2025 New “metabolic clock” could help detect early signs of disease and accelerated aging CIC bioGUNE Peer-Reviewed Publication
8-Sep-2025 New AI approach paves way for smarter T-cell immunotherapy and vaccine development Terasaki Institute for Biomedical Innovation Peer-Reviewed Publication
8-Sep-2025 Are patients undergoing surgery for early-stage cancer at risk of persistent opioid use? Wiley Peer-Reviewed Publication
7-Sep-2025 First-in-human trial shows promising results for DLL3-targeted antibody-drug conjugate SHR-4849 in relapsed small cell lung cancer International Association for the Study of Lung Cancer Reports and Proceedings
7-Sep-2025 Ifinatamab deruxtecan demonstrates high response rate in previously treated extensive-stage small cell lung cancer: Phase 2 IDeate-Lung01 trial International Association for the Study of Lung Cancer Reports and Proceedings
7-Sep-2025 Zidesamtinib shows durable responses in ROS1 TKI pre-treated NSCLC, including patients with CNS disease and ROS1 G2032R mutations International Association for the Study of Lung Cancer Reports and Proceedings
7-Sep-2025 Crizotinib fails to improve disease-free survival in resected early-stage ALK+ NSCLC International Association for the Study of Lung Cancer Reports and Proceedings
7-Sep-2025 Ivonescimab plus chemotherapy improves progression-free survival in patients with EGFR+ NSCLC following 3rd-generation EGFR-TKI therapy International Association for the Study of Lung Cancer Reports and Proceedings
7-Sep-2025 FLAURA2 trial shows osimertinib plus chemotherapy improves overall survival in eGFR-mutated advanced NSCLC International Association for the Study of Lung Cancer Reports and Proceedings
7-Sep-2025 Aumolertinib plus chemotherapy improves progression-free survival in NSCLC with EGFR and concomitant tumor suppressor genes: ACROSS 2 phase III study International Association for the Study of Lung Cancer Reports and Proceedings